Back to User profile » Dr Stefano Togni
Papers published by Dr Stefano Togni:
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Di Pierro F, Iqtadar S, Khan A, Ullah Mumtaz S, Masud Chaudhry M, Bertuccioli A, Derosa G, Maffioli P, Togni S, Riva A, Allegrini P, Khan S
International Journal of General Medicine 2021, 14:2807-2816
Published Date: 24 June 2021
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S
International Journal of General Medicine 2021, 14:2359-2366
Published Date: 8 June 2021
In vivo validation of the multicomponent powder (Vitachelox®) against the deposition of polluting ions
Giacomelli L, Togni S, Meneghin M, Eggenhöffner R, Maramaldi G
Clinical, Cosmetic and Investigational Dermatology 2018, 11:109-113
Published Date: 8 March 2018
Soothing and anti-itch effect of quercetin phytosome in human subjects: a single-blind study
Maramaldi G, Togni S, Pagin I, Giacomelli L, Cattaneo R, Eggenhöffner R, Burastero SE
Clinical, Cosmetic and Investigational Dermatology 2016, 9:55-62
Published Date: 26 February 2016
A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis
Togni S, Maramaldi G, Di Pierro F, Biondi M
Clinical, Cosmetic and Investigational Dermatology 2014, 7:321-327
Published Date: 11 November 2014
Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™)
Maramaldi G, Togni S, Franceschi F, Lati E
Clinical, Cosmetic and Investigational Dermatology 2014, 7:1-9
Published Date: 12 December 2013
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
Mazzolani F, Togni S
Clinical Ophthalmology 2013, 7:939-945
Published Date: 22 May 2013
Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva®), nimesulide, and acetaminophen
Di Pierro F, Rapacioli G, Di Maio EA, Appendino G, Franceschi F, Togni S
Journal of Pain Research 2013, 6:201-205
Published Date: 8 March 2013
Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
Mazzolani F
Clinical Ophthalmology 2012, 6:801-806
Published Date: 28 May 2012